Association for Ocular Pharmacology and Therapeutics

AOPT is committed to catalyzing scientific progress by promoting rigorous research, facilitating collaboration between academia, industry, and regulatory stakeholders, and enabling the development of next-generation therapeutics, including small molecules, biologics, and advanced modalities. The organization prioritizes forward-looking dialogue to identify unmet clinical needs and define future intervention strategies in ophthalmology and vision science.

As a convening body, AOPT cultivates an environment of transparent and constructive engagement, supporting the integration of scientific discovery with clinical application and commercial translation. It actively contributes to workforce development by fostering high-quality training, mentorship, and professional growth opportunities across career stages, with particular emphasis on equipping trainees and early-career scientists with skills in peer review, critical thinking, and translational research.

AOPT also functions as a global think tank, connecting emerging and mid-sized biopharmaceutical enterprises with investors and collaborators, while supporting decentralized scientific exchange through regional and virtual forums worldwide. By empowering diverse voices—including trainees—to shape the future of the field, AOPT advances a collaborative, inclusive, and innovation-driven ecosystem.

Ultimately, AOPT is dedicated to improving patient outcomes by accelerating the development, evaluation, and implementation of safe and effective ocular therapeutics across the full spectrum of modalities, including biologics.